HALO logo
halo search icon
Alexion Pharmaceuticals, Inc.

US$182.50

Price Change Indicator
3.05 (1.70%)
Alexion Pharmaceuticals, Inc.
ALXN · NAS

Alexion Pharmaceuticals, Inc.

Start Trading ALXN for Free

US$182.50

Price Arrow3.05 (1.70%)
20/07/2021 12:00:00 AM
All-Companies
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Alexion Pharmaceuticals, Inc. Overview

ALXN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ALXN

icon
icon

Telephone

1.475.230.2596

icon

Address

121 Seaport Boulevard, Boston, MA 02210

Description

Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.

ALXN Price Chart

Key Stats

Market Cap

n/a

PE

57.50

EV/EBITDA

9.3

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 99.91 - 187.45

Trade Value (12mth)

US$0.00

1 week

0%

1 month

0%

YTD

0%

1 year

0%

All time high

208.88

Key Fundamentals

EPS 3 yr Growth

38.50%

EBITDA Margin

52.90%

Operating Cashflow

$3,003m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

47.70

Quick Ratio

3.10

Other Data

Shares Outstanding (Fully Diluted)

223m

HALO Sector

Healthcare

Next Company Report Date

04-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ALXN Announcements

Latest Announcements

DateAnnouncements
16 February 21
16 February 21
08 February 21
08 February 21
04 February 20

ALXN Fundamentals

Per Share Records

Historical data

Forecast data

USD2016201720182019201820192020202120222023
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock0.3510.772.74locklocklock
EPS (Fully Diluted)
 $locklocklocklock0.3510.72.72locklocklock
Growth
 %locklocklocklock-82.42,991.8-74.5locklocklock
PE
 Xlocklocklocklock281.610.157.5locklocklock
EV/EBITDA
 Xlocklocklocklock11.87.69.3locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Alexion Pharmaceuticals, Inc. (ALXN:NAS)?
Halo FAQ
The current share price of Alexion Pharmaceuticals, Inc. (ALXN:NAS) is USD$182.50.
What is the 52-week high share price for Alexion Pharmaceuticals, Inc. (ALXN:NAS)?
Halo FAQ
The 52-week high share price for Alexion Pharmaceuticals, Inc. (ALXN:NAS) is USD$187.45.
What is the 52-week low share price for Alexion Pharmaceuticals, Inc. (ALXN:NAS)?
Halo FAQ
The 52-week low share price for Alexion Pharmaceuticals, Inc. (ALXN:NAS) is USD$99.91.
What is the dividend yield for Alexion Pharmaceuticals, Inc. (ALXN:NAS)?
Halo FAQ
Alexion Pharmaceuticals, Inc. (ALXN:NAS) does not pay a dividend.
What was Alexion Pharmaceuticals, Inc. (ALXN:NAS) last dividend payment?
Halo FAQ
Alexion Pharmaceuticals, Inc. (ALXN:NAS) does not pay a dividend.
What is the franking level for Alexion Pharmaceuticals, Inc. (ALXN:NAS)?
Halo FAQ
Alexion Pharmaceuticals, Inc. (ALXN:NAS) has a franking level of 0.00%.
In which sector is Alexion Pharmaceuticals, Inc. (ALXN:NAS) classified?
Halo FAQ
Alexion Pharmaceuticals, Inc. (ALXN:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Alexion Pharmaceuticals, Inc. (ALXN:NAS)?
Halo FAQ
The current P/E ratio for Alexion Pharmaceuticals, Inc. (ALXN:NAS) is 57.50.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial